Guillaume Meynard

Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)

Astrid Lièvre, Anthony Turpin, Isabelle Ray‐Coquard et al. · European Journal of Cancer · 2020 · 163 citations · Full text

Solid Cancer Patients, Cancer Epidemiology, Disease Risk Assessment +12

Study of the SARS-CoV-2-specific immune T-cell responses in COVID-19-positive cancer patients

Laura Mansi, Laurie Spehner, Étienne Daguindau et al. · European Journal of Cancer · 2021 · 33 citations · Full text

Cancer Immunosurveillance, Covid-19-positive Cancer Patients, T-regulatory Cell +7

A Phase II Study Evaluating the Interest to Combine UCPVax, a Telomerase CD4 TH1-Inducer Cancer Vaccine, and Atezolizumab for the Treatment of HPV Positive Cancers: VolATIL Study

Magali Rebucci-Peixoto, Angélique Vienot, Olivier Adotévi et al. · Frontiers in Oncology · 2022 · 26 citations · Full text

Cardiotoxicity is mitigated after a supervised exercise program in HER2-positive breast cancer undergoing adjuvant trastuzumab

Quentin Jacquinot, Nathalie Méneveau, Antoine Falcoz et al. · Frontiers in Cardiovascular Medicine · 2022 · 24 citations · Full text

Systemic high-dose intravenous methotrexate in patients with central nervous system metastatic breast cancer

Fernando Bazán, Erion Dobi, Bernard Royer et al. · BMC Cancer · 2019 · 18 citations · Full text